| 2008-August-20 |
12 Month Phase 3 Trial Finds Bronchitol Safe in Bronchiectasis (in PDF) |
| 2008-August-18 |
Bronchitol Phase 3 Cystic Fibrosis Trial Completes Recruitment (in PDF) |
| 2008-August-12 |
Bronchitol Cystic Fibrosis Dose Trial Results Positive (in PDF) |
| 2008-July-21 |
Pharmaxis Investor Conference Call (in PDF) |
| 2008-June-24 |
New Pharmaxis Board Appointment (in PDF) |
| 2008-June-20 |
Pharmaxis Concludes Special Protocol Assessment with FDA for Bronchitol Phase 3 Trial (in PDF) |
| 2008-June-17 |
Pharmaxis Establishes Named Patient Program for Bronchitol (in PDF) |
| 2008-June-12 |
Long-Term Safety Study of Bronchitol Completes (in PDF) |
| 2008-May-19 |
Pharmaxis' Aridol Authorised for Sale in Germany (in PDF) |
| 2008-May-1 |
Regulatory Path for Bronchitol in Bronchiectasis (in PDF) |
| 2008-April-11 |
Pharmaxis Investor Conference Call (in PDF) |
| 2008-April-4 |
Cystic Fibrosis Trial in Children Returns Positive Data (in PDF) |
| 2008-March-28 |
AridolTM Endorsed by International Olympic Committee (in PDF) |
| 2008-March-7 |
Pharmaxis's First Steps into China (in PDF) |
| 2008-February-14 |
Pharmaxis to Apply to Market Bronchitol in Australia (in PDF) |
| 2008-February-5 |
Pharmaxis Investor Conference Call (in PDF) |
| 2008-January-17 |
Pharmaxis' Aridol Gains First Asian Approval (in PDF) |
| 2007 |
2007 Press Releases |
| 2006 |
2006 Press Releases |
| 2005 |
2005 Press Releases |
| 2004 |
2004 Press Releases |